# Outcome-targeted Therapy: Principle and Outcome Evaluation: Clinical Study and Phenotype-genotype Correlation

> **NCT06632834** · PHASE2 · RECRUITING · sponsor: **National Taiwan University Hospital** · enrollment: 230 (estimated)

## Conditions studied

- Dilated Cardiomyopathy

## Interventions

- **DRUG:** simvastatin therapy

## Key facts

- **NCT ID:** NCT06632834
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-08-15
- **Primary completion:** 2025-01-19
- **Final completion:** 2025-01-19
- **Target enrollment:** 230 (ESTIMATED)
- **Last updated:** 2024-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06632834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06632834, "Outcome-targeted Therapy: Principle and Outcome Evaluation: Clinical Study and Phenotype-genotype Correlation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06632834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*